OpGen

OpGen Operating Expenses

The Total Operating Expenses of OpGen (OPGN) as of Oct 20, 2026 is 3.14 M USD. In the previous year, Total Operating Expenses was 4.76 M USD — a change of -34.09% (lower).

Operating Expenses

3.14 MUSD

YoY

-34.09%

Last updated:

Total Operating Expenses of OpGen is 2025 3.14 M USD. Total Operating Expenses of OpGen was 2024 4.76 M USD. It decreases by -34.09% lower compared to the previous year.

The OpGen Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2018
12.75 M USD
Jan 1, 2019
11.37 M USD
Jan 1, 2020
18.77 M USD
Jan 1, 2021
20.85 M USD
Jan 1, 2022
17.06 M USD
Jan 1, 2023
12.82 M USD
Jan 1, 2024
4.76 M USD
Jan 1, 2025
3.14 M USD
The OpGen Operating Expenses history
YEAROperating ExpensesYoY
3.14 MUSD-34.09%
4.76 MUSD-62.83%
12.82 MUSD-24.87%
17.06 MUSD-18.18%
20.85 MUSD+11.08%
18.77 MUSD+65.01%
11.37 MUSD-10.77%
12.75 MUSD-6.07%
13.57 MUSD-10.82%
15.22 MUSD+23.07%
12.36 MUSD+85.06%
6.68 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OpGen Stock analysis

What does OpGen do? OpGen Inc is a biotechnology company based in Gaithersburg, Maryland, operating within the Health Care sector. The company went public on May 5, 2015, with ticker OPGN and ISIN US68373L5057. It currently employs three people. OpGen develops molecular information solutions focused on combating infectious diseases in global healthcare settings. The company's technology involves DNA tests and bioinformatics to address antibiotic resistance, assisting healthcare providers in managing patient care decisions and monitoring the spread of multidrug-resistant microorganisms. Its solutions aim to guide clinicians with information about life-threatening infections and help manage patient outcomes. The company's website is http://opgen.com/. OpGen is engaged in creating tools to help protect the hospital biome through customized screening and surveillance. The firm markets its high-resolution DNA tests under the Acuitas trade name. The company has a global network of customers and partners. OpGen does not provide specific details on its product names beyond Acuitas, and no additional financial figures or historical data are available in the provided information. OpGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OpGen stock

Total Operating Expenses of OpGen is 3.14 M USD in 2025.

Total Operating Expenses of OpGen changed from 4.76 M USD to 3.14 M USD, representing a -34.09% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses OpGen since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's OpGen historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — OpGen

All Key Metrics — OpGen